Real-time enrollment status for this chronic obstructive pulmonary disease (copd) clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 4:59 AM UTC
| NCT Number | NCT07587658 |
| Recruiting Status | Recruiting |
| Condition | Chronic Obstructive Pulmonary Disease (COPD) |
| Phase | PHASE4 |
| Target Enrollment | 754 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | October 16, 2026 (Yesterday) |
As of October 17, 2026: Clinical trial NCT07587658 is currently recruiting participants. This phase4 study for chronic obstructive pulmonary disease (copd) is actively seeking new participants at 1 location across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07587658 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07587658 was last updated Yesterday (October 16, 2026). HelloStudys verifies this status automatically.